Citation tools
"The Orally Active ETA Receptor Antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid (LU 135252) Prevents the Development of Pulmonary Hypertension and Endothelial Metabolic Dysfunction in Monocrotaline-Treated Rats
." Journal of Pharmacology and Experimental Therapeutics
282.3
(1997):
1312-1318.
Web. 19 April. 2024.